Coronavirus-19, monocyte/macrophage glycolysis and inhibition by melatonin
Abstract: Two highly relevant studies related to SARS-CoV-2 and coronavirus disease (COVID-19) and supporting the use of melatonin to prevent and treat this serious infection were published recently. Campos-Codo and colleagues [1] documented experimentally their claim that drugs which specifica...
Guardado en:
| Autores principales: | Reiter, R., Sharma, Ramaswamy, Castillo, Rafael, Marik, Paul E., Domínguez Rodriguez, Alberto, Cardinali, Daniel Pedro, Tesarik, Jan |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Wright Academia
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/13642 |
| Aporte de: |
Ejemplares similares
-
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
por: Reiter, Russel J., et al.
Publicado: (2022) -
Low melatonin as a contributor to SARS-CoV-2 disease
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2022) -
An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022) -
Autism spectrum disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2024) -
La pandemia por el nuevo coronavirus COVID-19
por: Cuestas, Eduardo
Publicado: (2020)